Literature DB >> 30890118

Modeling economic and epidemiological impact of voluntary medical male circumcision among men who have sex with men in Beijing, China.

Chen Zhang1,2, David F Penson3,2, Han-Zhu Qian4,2, Glenn F Webb5,2, Jie Lou6,2, Brian E Shephard7,2, Yu Liu8,2, Sten H Vermund4,2.   

Abstract

Voluntary medical male circumcision (VMMC) among men who have sex with men (MSM) may protect against HIV acquisition. We conducted a series of analyses to assess if expanded VMMC might reduce HIV incidence among MSM effectively and economically. We used a deterministic compartmental model to project new HIV cases (2016-2026) under annual VMMC coverage rates (λ) ranging from 0.0001 to 0.15. The 'number needed to avert' (NNA) is defined as the cumulative number of VMMCs conducted up to that year divided by the cumulative number of HIV cases averted in that specific year. Compared with the baseline circumcision coverage rate, we projected that new HIV cases would be reduced with increasing coverage. By 2026 (last year simulated), the model generated the lowest ratio (11.10) when the annual circumcision rate was the most optimistic (λ = 0.15). The breakeven point was observed at the year of 2019 with the annual VMMC coverage rate of 0.001. The total cost saved by averting HIV cases would range from 2.5 to 811 million US dollars by the end of 2026 with different hypothetical coverage rates. Our model suggests that acceleration in VMMC implementation among MSM could help stem the HIV/AIDS epidemic.

Entities:  

Keywords:  China; HIV; Male circumcision; men who have sex with men; ‘number needed to avert’ analysis

Mesh:

Year:  2019        PMID: 30890118      PMCID: PMC6666307          DOI: 10.1177/0956462419831859

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  44 in total

1.  How willing are men who have sex with men in China to be circumcised for the sake of protecting his female sex partner?

Authors:  Joseph T F Lau; Hongjing Yan; Chunqing Lin; Jun Zhang; Kai-Chow Choi; Zhijun Wang; Chun Hao; Xiping Huan; Haitao Yang
Journal:  J Sex Med       Date:  2010-11-22       Impact factor: 3.802

2.  Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

3.  Anal sex role, circumcision status, and HIV infection among men who have sex with men in Chongqing, China.

Authors:  Chao Zhou; H Fisher Raymond; Xianbin Ding; Rongrong Lu; Jing Xu; Guohui Wu; Liangui Feng; Song Fan; Xuefeng Li; Willi McFarland; Yan Xiao; Yuhua Ruan; Yiming Shao
Journal:  Arch Sex Behav       Date:  2012-10-16

Review 4.  Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis.

Authors:  Gregorio A Millett; Stephen A Flores; Gary Marks; J Bailey Reed; Jeffrey H Herbst
Journal:  JAMA       Date:  2008-10-08       Impact factor: 56.272

5.  Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.

Authors:  Emmanuel Njeuhmeli; Steven Forsythe; Jason Reed; Marjorie Opuni; Lori Bollinger; Nathan Heard; Delivette Castor; John Stover; Timothy Farley; Veena Menon; Catherine Hankins
Journal:  PLoS Med       Date:  2011-11-29       Impact factor: 11.069

6.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

7.  Cost-effectiveness of male circumcision for HIV prevention in a South African setting.

Authors:  James G Kahn; Elliot Marseille; Bertran Auvert
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

8.  Acceptability of Condoms, Circumcision and PrEP among Young Black Men Who Have Sex with Men: A Descriptive Study Based on Effectiveness and Cost.

Authors:  Richard A Crosby; Angelica Geter; Ralph J DiClemente; Laura F Salazar
Journal:  Vaccines (Basel)       Date:  2014-02-18

9.  Modeling the impact on HIV incidence of combination prevention strategies among men who have sex with men in Beijing, China.

Authors:  Jie Lou; Meridith Blevins; Yuhua Ruan; Sten H Vermund; Sanyi Tang; Glenn F Webb; Bryan E Shepherd; Xiong He; Hongyan Lu; Yiming Shao; Han-Zhu Qian
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  Can male circumcision have an impact on the HIV epidemic in men who have sex with men?

Authors:  Steven M Goodreau; Nicole B Carnegie; Eric Vittinghoff; Javier R Lama; Jonathan D Fuchs; Jorge Sanchez; Susan P Buchbinder
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more
  4 in total

1.  Predicting the long-term impact of voluntary medical male circumcision on HIV incidence among men who have sex with men in Beijing, China.

Authors:  Chen Zhang; Glenn F Webb; Jie Lou; Brian E Shepherd; Han-Zhu Qian; Yu Liu; Sten H Vermund
Journal:  AIDS Care       Date:  2019-10-16

Review 2.  Interventions to improve the HIV continuum of care in China.

Authors:  Xiangjun Zhang; Na Wang; Sten H Vermund; Huachun Zou; Xianhong Li; Fujie Zhang; Han-Zhu Qian
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

Review 3.  Voluntary medical male circumcision and HIV infection among men who have sex with men: Implications from a systematic review.

Authors:  Chen Zhang; Han-Zhu Qian; Yu Liu; Sten H Vermund
Journal:  SAGE Open Med       Date:  2019-08-08

4.  Critical evaluation of arguments opposing male circumcision: A systematic review.

Authors:  Brian J Morris; Stephen Moreton; John N Krieger
Journal:  J Evid Based Med       Date:  2019-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.